ArticleGeroScience2025
Healthy diet and slower biological aging as protective factors against microvascular complications in type 2 diabetes.
Article in GeroScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Look AHEAD Research Program: A 25-Year Retrospective From the Perspective of Geroscience.Diabetes care · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
This study aimed to evaluate the independent and joint effects of adherence to healthy dietary patterns and slower biological aging on the incidence of diabetic microvascular complications in individuals with type 2 diabetes mellitus (T2DM), and to assess the mediating role of biological aging. In a prospective cohort of 13,294 T2DM participants without baseline DMCs, dietary quality was assessed using a validated 10-point score, while biological aging was calculated from nine biomarkers and chronological age. Cox regression models were used to assess associations, and mediation analysis was performed to estimate the mediating effects of biological aging. Over a mean follow-up of 11.9 years, 3197 participants developed DMCs, including 1392 cases of diabetic retinopathy (DR), 1908 of diabetic nephropathy (DN), and 598 of diabetic neuropathy (DPN). Higher dietary scores (6-10) were associated with reduced risks of composite DMCs (HR 0.845; 95% CI 0.742-0.962), DR (0.804; 0.659-0.981), and DN (0.766; 0.643-0.911), but not DPN. Phenotypic age acceleration (PhenoAgeAccel) ≤ 0 was also linked to a reduced risk of DMCs. In addition, biologically younger with higher dietary score (6-10 points) had 39.4%, 30.8%, 53.6%, and 41.9% lower risk of composite DMCs, DR, DN, and DPN, respectively. Mediation analysis revealed that PhenoAgeAccel accounted for 43.0%, 29.8%, and 33.5% of the diet association with composite DMCs, DR, and DN, respectively. The results suggest that healthier dietary patterns and slower biological aging can reduce the risk of DMCs in T2DM patients, with a substantial portion of the dietary benefits mediated through slower aging. Integrating dietary and aging-targeted interventions may offer a promising method to reduce DMC risk in T2DM.
Indexed as
Identifiers
41379288What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.